Dr. Gahimer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1703 W Stones Crossing Rd
Ste 200
Greenwood, IN 46143Phone+1 317-859-3737Fax+1 317-859-3730
Education & Training
Indiana University School of MedicineResidency, Internal Medicine, 1985 - 1988- Indiana University School of MedicineClass of 1985
Certifications & Licensure
IN State Medical License 1987 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Diabetes Recognition Program National Committee for Quality Assurance, 2013-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 23 citationsHepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic eventsJoachim F. Wernicke, Nayan Acharya, James Gahimer, Deborah N. D'Souza, Natalie DiPietro
Current Drug Safety. 2008-05-01 - 78 citationsA retrospective pooled analysis of duloxetine safety in 23 983 subjectsJames Gahimer, Joachim F. Wernicke, Ilker Yalcin, Melissa J. Ossanna, Meghan Wulster-Radcliffe
Current Medical Research and Opinion. 2007-01-01 - 39 citationsSafety and adverse event profile of duloxetine.Joachim F. Wernicke, James Gahimer, Ilker Yalcin, Meghan Wulster-Radcliffe, Lars Viktrup
Expert Opinion on Drug Safety. 2005-10-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
